UNSPSC 41202036: Leptospira spp. serological reagents

In this classification, Leptospira genus serological reagents are devices used in test to identify specific Leptospira genus antibodies in serum. US FDA regulates Leptospira genus serological reagents under 21 CFR 866.3350 and under FDA product code GRY.

UNSPSC 41202036 Leptospira spp. serological reagents is a Commodity code that covers diagnostic test kits and reagents for infectious disease screening and detection, though the recent state and local opportunities posted under this code diverge significantly from the code's stated scope — solicitations are actually targeting HIV, syphilis, and drugs-of-abuse testing supplies rather than Leptospira serological reagents. State and local issuing bodies pursuing procurement under or near this code span public health departments, county criminal justice agencies, county health services, and municipalities. Illinois Department of Public Health, Collin County in Texas, Gwinnett County in Georgia, and the City of Austin appear as repeat or recent buyers. The actual scope of work reflects laboratory reagent supply agreements tied to specific analyzer platforms — Abbott ARCHITECT systems for HIV and syphilis testing at Illinois IDPH's Carbondale Laboratory; Hologic Panther NAAT platforms for sexually transmitted infection testing; and drugs-of-abuse analyzer consumables for offender testing programs. Reagent procurement often bundles calibrators, controls, consumables, maintenance services, and turnkey rental agreements that include instrumentation, training, and technical support.

Recent opportunities cluster in Texas and Illinois, with secondary activity in Georgia and Austin. The Illinois Department of Public Health has posted multiple emergency and standard procurements for Abbott HIV/Syphilis reagents (May and September 2026), including a change order for Contract 68500013N (due October 13, 2026) increasing annual NG/CT testing from 15,000 to 25,000 tests and kits from 15,000 to 30,000 units, with total contract cost revised to $900,000 over five years. The City of Austin issued two HIV test kit IFBs for rapid Abbott Determine kits (June and August 2026, with the rebid due September 3, 2026) for approximately 375 test kits and 79 control kits annually. Collin County's RFP 2026-327 for offender specimen collection and drug testing services (responses due July 23, 2026, estimated value $600,000 over two years with three optional renewals) encompasses immunoassay screening, LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, and staffing two collection sites. Gwinnett County posted an RFP for drug testing supplies for a drugs-of-abuse analyzer (due October 14, 2026) with limited detail available. The Illinois emergency procurement (May 2026) awarded $38,079.50 in sole-source Abbott reagents to maintain CLIA certification and testing operations.